LAS VEGAS, Nov. 22, 2017 (GLOBE NEWSWIRE) -- In 2012, the global personalized medicine market was evaluated around USD 806.97 billion and is expected to reach approximately USD 5208.68 billion by 2022 while registering itself at a compound annual growth rate (CAGR) of 12.01% over the forecast period. Major driving factors of the global market are increasing development of whole genome, companion diagnostics, next-generation sequencing technology, and rising retail clinics. Rising healthcare spending levels stimulating the demand for an efficient cancer diagnostic procedure, rising incidence of cancer and growing utilization of amalgamation biomarkers for diagnostics are some factors projected to boost the growth of the global market. Rising implementation of next-generation sequencing by medical practitioners and clinicians for genetic mapping of patients worldwide and increasing support for the personalized drug by regulatory and reimbursement landscape are also expected driving factors for global demand over 2022. Global market growth is also projected to augment via the new drugs introduction that is linked and companion diagnostics, and increasing usage of accurate and extremely sensitive genetic diagnostic method for disease testing as well as risk assessment. The expected rise in advanced DNA diagnostic use along with the decline in implementation price for whole genome sequencing is anticipated to significantly increased rates.

Scope of the Report

This report focuses on the Personalized Medicine (PM) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. This report covers collaborations in the field along with new product launches, competitive landscape analysis listing out the mergers, acquisitions, comparative financial studies and recent strategic developments in the market by the major companies.

Book Your Sample Copy of the Report here - http://www.crystalmarketresearch.com/report-sample/HC11358

The report Personalized Medicine (PM) Market render a wide-ranging analysis of the said market in terms of product, regional, application and end user segmentation. The report comprises of the present market size of this industry. Also, the potential outlooks and current market summary of this segment has been thoroughly analyzed in this report. Moreover, chief market players of the Personalized Medicine (PM) Market are studied on various factors like product portfolio, company profile, sales analysis, revenue generation through the forecast period.

Major Market Players

uest Diagnostics

3G Biotech

Laboratory Corporation of America

Agendia NV

Abbott

AsuragenInc

CardioDx Inc.

Becton Dickinson & Co.

Foundation Medicine Inc.

Siemens Healthcare Diagnostics Inc.

Qiagen Inc.

Amgen Inc.

GE Healthcare

Bristol-Myers Squibb

Pfizer Inc.

23andMe

Sanofi

Illumina Inc.

Astra Zeneca PLC

Roche Holding AG

Vertex Pharmaceuticals Inc.

American Association for Cancer Research

Merck & Co. Inc.

To Grab the Complete Report, Please Visit: http://www.crystalmarketresearch.com/report/personalized-medicine-pm-market

Table of Contents

1. Introduction

1.1. Report Description

1.2. Research Methodology

1.2.1. Secondary Research

1.2.2. Primary Research

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.1.1. Increasing number of associated diagnostics

3.2.1.2. Rising healthcare spending generating development of effective PM diagnostic & therapeutic

3.2.1.3. Growing prevalence of cancer

3.2.2. Restraints

3.2.2.1. Lack of Technologies

3.2.2.2. Absence of appropriate intellectual property regulations for personalized medical technologies

3.2.3. Opportunities

3.2.3.1. Technological Advancement in Development of Personalized Medicines

4. Personalized Medicine (PM) Market, By Application

5. Personalized Medicine (PM) Market, By Region

6. Company Profiles

Ask For Customization: http://www.crystalmarketresearch.com/customization/HC11358

Efficiency of this Report

The report Personalized Medicine (PM) Market by Manufacturers focuses on fundamental segments of this sector. This report consists of Segment wise in-depth analysis in terms of product, application and end user along with market size forecasts and estimations to perceive significant areas of industry growth in detail. Additionally, an executive summary, condensing the entire report in such a way that decision-making team can swiftly become familiar with background information, summarizing analysis and main conclusions.

Contact Us:

Judy

304 South Jones Blvd, Suite 1896,

Las Vegas NV 89107,

United States

Toll Free: +1-888-213-4282

Email: sales@crystalmarketresearch.com

Website: www.crystalmarketresearch.com



